Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-6009
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?! ; volume:2 ; number:3 ; day:21 ; month:9 ; year:2011 ; pages:121-123 ; date:9.2011
Journal of cachexia, sarcopenia and muscle ; 2, Heft 3 (21.9.2011), 121-123, 9.2011
- Urheber
-
Thum, Thomas
Springer, Jochen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13539-011-0040-8
- URN
-
urn:nbn:de:101:1-2023050321143537608827
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thum, Thomas
- Springer, Jochen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment of osteoporosis using a selective androgen receptor modulator ostarine in an orchiectomized rat model
Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization
Comparison of in vitro approaches for predicting the metabolism of the selective androgen receptor modulator RAD140
Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases
Effect of Selective Androgen Receptor Modulator Enobosarm on Bone Healing in a Rat Model for Aged Male Osteoporosis
Idiosyncratic drug-induced liver injury related to use of novel selective androgen receptor modulator RAD140 (Testalone): a case report
Cachexia
Cachexia
Breakthrough
Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes
![[Cachexia - Cynanche]](https://iiif.deutsche-digitale-bibliothek.de/image/2/6380b146-415b-4259-9488-61657435a8c1/full/!306,450/0/default.jpg)
[Cachexia - Cynanche]
Cachexia Scorbutica
Treatment of osteoporosis using a selective androgen receptor modulator ostarine in an orchiectomized rat model
Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization
Comparison of in vitro approaches for predicting the metabolism of the selective androgen receptor modulator RAD140
Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases
Effect of Selective Androgen Receptor Modulator Enobosarm on Bone Healing in a Rat Model for Aged Male Osteoporosis
Idiosyncratic drug-induced liver injury related to use of novel selective androgen receptor modulator RAD140 (Testalone): a case report
Cachexia
Cachexia
Breakthrough
Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes
[Cachexia - Cynanche]
Cachexia Scorbutica
Treatment of osteoporosis using a selective androgen receptor modulator ostarine in an orchiectomized rat model
Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization
Comparison of in vitro approaches for predicting the metabolism of the selective androgen receptor modulator RAD140
Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases
Effect of Selective Androgen Receptor Modulator Enobosarm on Bone Healing in a Rat Model for Aged Male Osteoporosis
Idiosyncratic drug-induced liver injury related to use of novel selective androgen receptor modulator RAD140 (Testalone): a case report
Cachexia
Cachexia
Breakthrough
Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes
[Cachexia - Cynanche]